Skip to main content
. 2020 Aug 21;8:763. doi: 10.3389/fcell.2020.00763

FIGURE 3.

FIGURE 3

Results of protein studies by Western blot and ELISA in different regions of Rett Syndrome (RTT) and control brain tissues. (A) Western blot results for MeCP2 isoforms quantified and analyzed in four brain regions (frontal cerebrum, hippocampus, amygdala, and cerebellum) for mean of controls show non-significant variations between the regions. (B) Western blot results for MeCP2 isoforms quantified and analyzed in four brain regions for mean of RTTs show higher level of MeCP2E1 isoform in the cerebellum compared to the frontal cerebrum or hippocampus. (C) Mean of MeCP2 isoforms in RTT and controls are not significantly different in relative RTT/control analysis. (D) Western blot results for ProBDNF quantified and analyzed in four brain regions for mean of controls and RTTs show non-significant inter-regional variations without significant difference between RTT and controls. (E) ELISA results for BDNF quantified and analyzed in four brain regions for mean of controls and RTTs show significantly higher levels in Hippocampus compared to frontal cerebrum and cerebellum of the controls. (F) Mean of ProBDNF and BDNF in RTT and controls are not significantly different in relative RTT/Control analysis. Frontal cerebrum (Fc); Hippocampus (Hp); Amygdala (Am); Cerebellum (Cb); N = 3 ± Standard Error of the Mean (SEM); One-way ANOVA (ELISA)/Kruskal-Wallis test (WB) with multiple pairwise comparisons used among different brain regions. Student’s t-test (ELISA)/Mann-Whiney test (WB) was used to compare controls and RTT samples for each parameter. The significance level was determined at P < 0.05 (#).